WASHINGTON — A panel of federal experts said Friday an anti-itching drug from eye care company Ista Pharmaceuticals is safe and effective, according to a government spokeswoman.
The unanimous vote from the seven members of the Food and Drug Administration's opthalmic panel amounts to a recommendation for approval. Although the FDA is not required to follow the group's advice, it usually does.
Shares of Irvine, Calif.-based Ista Pharmaceuticals rose 21 cents, or 4.9 percent, to $4.45 in afternoon trading.
Ista is asking the FDA to approve its formula Bepreve to relieve itchiness caused by seasonal allergies.
A final decision on the drug is expected by September.
Bepreve is one of two developmental products considered critical to Ista's business outlook. The other is an experimental topical steroid for eye infections, called T-Pred, which is also under FDA review.
Filed under Eye Care Program, News | Tags: Allergies, Diseases And Conditions, eye, eye care, Health Care Industry, Us-ista-pharmaceuticals-fda, Washington | Comment Below
Related?FDA says Ista Pharmaceuticals' eye drug Bepreve did not show serious adverse effects in testsJune 24th, 2009 FDA says Ista eye drug has no serious side effectsWASHINGTON — Federal health scientists said Wednesday an anti-itching drug from eye care company Ista Pharmaceuticals did not show any serious side effects in testing on patients. Ista is asking the Food and Drug Administration to approve its formula Bepreve to relieve itchiness caused by seasonal allergies. Combination Antibiotic-Steroid for Ocular Inflammation Filed for FDA ApprovalJuly 8th, 2006 ISTA Pharmaceuticals Inc., which develops eye-care treatments said Thursday it filed a new drug application with the U.S. Food and Drug Administration for its combination antibiotic steroid to fight ocular inflammation. Preliminary analysis of Xibrom QD announced to be satisfyingDecember 5th, 2008 ISTA Pharmaceuticals Inc. announced the preliminary analysis of a late-stage trial in Xibrom QD. About eye allergy sufferers: A survey report of AAFAMay 29th, 2009 A new survey conducted by the Asthma & Allergy Foundation of America (AAFA) to help allergy sufferers better understand and manage the condition. Major findings:
* Spring was identified by 67% of respondents as the most troublesome time of year for eye-related allergies. Queensland Health Minister Backs Strategy for Rapid Cataract Surgery May 23rd, 2008 The Queensland health Minister Mr Stephen Robertson has supported the new strategy that is likely to be in favor of the patients of cataract surgery at the Herbey Bay Hospital. The strategy will be helpful for patients who have to wait for long hours for the surgery. How to Determine Appropriate Contact LensesJuly 28th, 2006 Different contact lenses suit different people and there are many factors which determine which the best ones are for each individual and indeed whether they are appropriate at all. Although it is always best to seek advice from an optometrist, Onestopcontactlenses.co.uk has put together a guide to help people choose the right type of lenses for them. Pharmaceuticals maker Novartis posts 14 percent drop in first-quarter net profitApril 23rd, 2009 Novartis posts 14 percent drop in 1Q profitGENEVA — Pharmaceuticals maker Novartis AG reported Thursday a 14 percent decline in first-quarter net profit in part due to shifts in currency values as well as the cost of financing its takeover of the Alcon eye care company. Novartis said the profit of $1.98 billion compared with $2.3 billion in the first quarter of 2008, but that its pharmaceuticals division performed well, with recently launched products rejuvenating the portfolio. Protease Inhibitor ASP-440 may help treat diabetic retinopathy January 23rd, 2009 Scientists have demonstrated that ASP-400 a specific inhibitor of the protease plasma kallikrein may provide a new therapeutic approach for the treatment of diabetic retinopathy. Researchers from Joslin Diabetic Centre, Boston, and ActiveSite Pharmaceuticals, Inc.,SanFrancisco, jointly conducted this study. FDA experts unanimously favor Ista Pharmaceuticals’ Bepreve for seasonal allergies
Get all the information and photos:: http://coringa.info/uncategorized/fda-experts-unanimously-favor-ista-pharmaceuticals-bepreve-for-seasonal-allergies
0 comments:
Post a Comment